The Latest Breaking News from UBS

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

A study by Women in Banking and Finance and the London School of Economics focuses on finance professionals in the U.K.

The FDA just approved its most expensive drug ever — a hemophilia gene therapy from CSL and UniQure — and QURE stock popped Wednesday.

The Dow Jones Industrial Average reversed Monday as President Biden and Chinese leader Xi Jinping held a closely watched meeting.

Stocks registered their biggest rally since 2020 yesterday, driven by the October inflation report that showed cooling price pressures. Moreover, the latest job report is raising hopes of a slower pace of rate hikes by the Fed. Therefore, we think it could be the right time for investors to buy…

Upgrades

Marcus Margulies faced allegations that he had concealed funds from a “secret” trust held in a Swiss bank account.

Amid the ongoing macroeconomic and geopolitical issues, the stock market has faced wild swings this year. As the sky-high inflation and the Fed’s aggressive rate hikes continue to heighten recessionary fears, Wall Street darlings Microsoft (MSFT), Pfizer (PFE), and Coca-Cola (KO), which have a solid dividend-paying record, might be ideal…

With the macroeconomic headwinds putting pressure on business margins, the market volatility is not expected to ease anytime soon. With the midterm elections adding to the unpredictability, investors would be best served by seeking refuge in geographically diversified and robust businesses, Microsoft (MSFT) and Walmart (WMT). These stocks promise consistent…

On the surface stocks just seem to be trading calmly in a trading range. Under the surface things are setting up for continuation of the bear market which is why UBS now predicts market bottom around 3,200 for the S&P 500 (SPY). Get 40 year investment veteran, Steve Reitmeister’s, updated…

German officials have searched UBS bank branches in Frankfurt and Munich as part of an investigation into suspected money-laundering by a Russian oligarch Alisher Usmanov.